Two new studies indicate that SARS-CoV-2 vaccines from Pfizer-BioNTech and Moderna elicit a lower neutralizing antibody responses against the B.1.351 viral lineage identified in South Africa, the Washington Post reports.
Two new studies indicate that SARS-CoV-2 vaccines from Pfizer-BioNTech and Moderna elicit a lower neutralizing antibody responses against the B.1.351 viral lineage identified in South Africa, the Washington Post reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.